Frontiers | New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness
An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer - eBioMedicine
Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer | Scientific Reports
KRAS mutation A treatment target
Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
Cureus | KRAS/NRAS/BRAF Mutation Rate in Saudi Academic Hospital Patients With Colorectal Cancer | Article
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
Targeting KRAS mutant cancers: from druggable therapy to drug resistance | Molecular Cancer | Full Text
IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations | Journal of Proteome Research
The Trouble With KRAS - Cancer Commons
Chemically modified MIR143-3p exhibited anti-cancer effects by impairing the KRAS network in colorectal cancer cells: Molecular Therapy - Nucleic Acids
Correlation between clinical data and molecular marker alterations in... | Download Scientific Diagram
Immune modulatory effects of oncogenic KRAS in cancer | Nature Communications
Cancers | Free Full-Text | Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
Integrated multi-omics characterization of KRAS mutant colorectal cancer
Cancers | Free Full-Text | KRAS in NSCLC: State of the Art and Future Perspectives
Cells | Free Full-Text | KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions
Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations | PLOS ONE
Hitting an Elusive Target in Pancreatic Cancer - NCI
A): Dynamic change in tumor marker (CA125) (blue line) and KRAS G12V... | Download Scientific Diagram
Combination of KRAS gene silencing and PI3K inhibition for ovarian cancer treatment - ScienceDirect
Molecular epidemiology and diagnostics of KRAS mutations in human cancer | SpringerLink
KRAS drives immune evasion in a genetic model of pancreatic cancer | Nature Communications
Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer: Cell
Frontiers | Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
KRAS Screening & Profiling
